Lydus Medical focuses on addressing the challenges associated with microvascular anastomosis, a critical procedure in various surgical fields such as cardiovascular, transplant, and reconstructive microsurgery. The company has developed the Vesseal™ device, an automated microvascular suturing tool designed to streamline the process of suturing ultra-small vessels ranging from 0.5 to 4mm in diameter. This innovative technology aims to enhance surgical efficiency by reducing ischemic time and operating room (OR) duration, thereby minimizing complications and costs associated with traditional hand suturing methods. The Vesseal™ device is characterized by its ease of use, safety profile, and suitability for various surgical settings, including robotic and laparoscopic procedures.

The Vesseal™ device employs a thread-only suturing technique, which eliminates the need for leaving any device within the body post-procedure. This feature not only simplifies the surgical process but also contributes to improved patient outcomes. The technology is applicable across a range of medical indications, including reconstructive surgery, organ transplantation, lymphedema treatment, neurovascular procedures, arteriovenous fistula creation, and peripheral bypass surgeries. By optimizing the microvascular suturing process, Lydus Medical aims to set a new standard in microsurgery, enhancing both the safety and effectiveness of these critical procedures.

Israel

Lydus Medical is a start-up company in the field of Microsurgery developing a novel system for automating the creation of a safe, simple and fast anastomosis.

Vesseal™ is an automated microvascular suturing device delivering thread only standardized omni-vessel anastomoses, to enable simple, fast, easy, safe and effective procedures.

Lydus Medical

Company Details